10 Results for "

Y705

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "Y705" in MCE Product Catalog:

314
314 Cited Publications
Cat. No.: HY-13818
CAS No.: 19983-44-9
Purity:  99.58%
Target:  

STAT Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

Stattic is a potent STAT3 inhibitor and inhibits STAT3 phosphorylation (at Y705 and S727) . Stattic inhibits the binding of a high affinity phosphopeptide for the SH2 domain of STAT3 . Stattic ameliorates the renal dysfunction in Alport syndrome (AS) mice .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-150603
CAS No.: 2248552-86-3
Purity:  99.24%
Research Areas:  

Cancer

STAT3-IN-13 (compound 6f) is a potent STAT3 inhibitor. STAT3-IN-13 has anti-proliferative effects and binds to the STAT3 SH2 domain with a KD of 0.46 μM. STAT3-IN-13 inhibits the phosphorylation of STAT3 Y705 and downstream target gene expression. STAT3-IN-13 induces apoptosis in vitro and suppresses the growth and metastasis of tumor in vivo. STAT3-IN-13 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-P10114
CAS No.: 400628-16-2
Synonyms: PpYLKTK-mts; STAT3 PI
Target:  

STAT

Research Areas:  

Cancer

STAT3-IN-24, cell-permeable (PpYLKTK-mts) is a STAT3 peptide inhibitor. STAT3-IN-24, cell-permeable inhibits recruitment of STAT3 to Jak2 and phosphorylation of Y705, thus preventing the dimerization and the nuclear translocation of STAT3 .
loading...
    loading...
Cat. No.: HY-112447
CAS No.: 1041438-68-9
Target:  

STAT

Research Areas:  

Cancer

STAT3-IN-5 is a potent STAT3 inhibitor. STAT3-IN-5 inhibits STAT3-Y705 phosphorylation with an EC50 value of 170 nM. STAT3-IN-5 inhibits cytokine induced JAK activation. STAT3-IN-5 induces apoptosis. STAT3-IN-5 can be used in research of cancer .
loading...
    loading...
Cat. No.: HY-13818R
CAS No.: 19983-44-9
Target:  

STAT Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

Stattic (Standard) is the analytical standard of Stattic. This product is intended for research and analytical applications. Stattic is a potent STAT3 inhibitor and inhibits STAT3 phosphorylation (at Y705 and S727) . Stattic inhibits the binding of a high affinity phosphopeptide for the SH2 domain of STAT3 . Stattic ameliorates the renal dysfunction in Alport syndrome (AS) mice .
loading...
    loading...
Cat. No.: HY-183628
Synonyms: 2-(4-Morpholinoanilino-6-[(2-exo-norbornyl) amino)-purine
Target:  

STAT

Research Areas:  

Endocrinology Cancer

MEAP (2-(4-Morpholinoanilino-6-[(2-exo-norbornyl) amino)-purine) is a NEDD9-STAT3 modulator. MEAP disrupts NEDD9-STAT3 interaction, driving STAT3 Y705 dephosphorylation. MEAP induces G2/M phase arrest. MEAP can be used for the research of anaplastic thyroid cancer .
loading...
    loading...
Cat. No.: HY-181514
CAS No.: 3113051-34-3
Target:  

STAT CDK c-Myc Apoptosis

Research Areas:  

Cancer

STAT3-IN-53 (Compound L20) is a STAT3 inhibitor with a Kd value of 6.16 μM. STAT3-IN-53 binds directly to the SH2 domain of STAT3, inhibits phosphorylation at the Y705 site without affecting the total STAT3 protein level, and suppresses the IL-6/JAK/STAT3 pathway. STAT3-IN-53 downregulates the transcription and expression of cyclin-D1 and c-Myc. STAT3-IN-53 induces cell cycle arrest and promotes Apoptosis. STAT3-IN-53 exhibits anticancer activity against colorectal cancer .
loading...
    loading...
Cat. No.: HY-P86737
Synonyms: STAT3(phospho Y705); p-STAT3(phospho Y705); phospho-Stat3(pTyr705); STAT3(phospho-Tyr705); p-STAT3(Tyr705); phosphorylated Stat3(pTyr705); p-Stat3; Acute Phase Response Factor; APRF; DNA binding protein APRF; FLJ20882; MGC16063; Signal Transductor and Activator of Transcription 3; STAT 3; STAT3_HUMAN.

Host:  

Mouse

Application:  

IHC-P, IHC-F, IF-Tissue

Reactivity:  

Human, Rat

loading...
    loading...
Cat. No.: HY-P86737A
Synonyms: STAT3(phospho Y705); p-STAT3(phospho Y705); phospho-Stat3(pTyr705); STAT3(phospho-Tyr705); p-STAT3(Tyr705); phosphorylated Stat3(pTyr705); p-Stat3; Acute Phase Response Factor; APRF; DNA binding protein APRF; FLJ20882; MGC16063; Signal Transductor and Activator of Transcription 3; STAT 3; STAT3_HUMAN.

Host:  

Mouse

Application:  

IHC-P, IHC-F, IF-Tissue

Reactivity:  

Human, Rat

loading...
    loading...
Cat. No.: HY-155949
CAS No.: 931305-29-2
Research Areas:  

Neurological Disease Cancer

Bt354 is an orally active STAT3 inhibitor with IC50 values of 4.6 μM (DU145), 6.5 μM (MDA-MB-435) and 7.2 μM (MDA-MB-231), respectively. Bt354 induces cell cycle arrest and apoptosis, and downregulates epithelial-mesenchymal transition-related genes. Bt354 exhibits anti-angiogenic and anti-inflammatory activities, attenuates the polarization of M1 microglia and A1 astrocytes, suppresses inflammasome-related signaling pathways, and alleviates mechanical hyperalgesia and thermal hyperalgesia. Bt354 can be used in research related to glioblastoma multiforme, triple-negative breast cancer, prostate cancer and neuropathic pain .
loading...
    loading...